Delivery Order SPE2DB24D1205-SPE2DB24FCUXE

Award Date 9/20/24
Potential Completion Date 10/11/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 100-unit vials of Botox, a prescription medication. The contract is a firm fixed-price delivery order with a ceiling value of $8,613.60 and a period of performance ending on June 18, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 100-unit vials of BOTOX. The $4,306.80 firm fixed-price contract has a completion date of July 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200 unit vials of BOTOX, a medication used for various medical purposes. The contract has a firm fixed price of $12,821.85 and a completion date of July 23, 2025. This contract is not set-aside and is awarded as part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a $11,642.60 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of BOTOX. The contract has an ultimate completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $58,213.00 firm fixed-price contract is for the delivery of BOTOX 200 unit vials. This delivery order falls under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 200-unit vials of Botox. The fixed-price contract has a ceiling value of $41,029.92 and a period of performance through June 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-unit vials of BOTOX with a ceiling value of $8,613.60. The contract is a Firm Fixed Price, non-set-aside award with a period of performance through July 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of Botox, a specialty medication, with a ceiling value of $1,204.50 and a completion date of December 27, 2024. The contract is a firm-fixed-price, delivery order contract type and was not set aside for a specific business category. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $61,123.65 firm fixed-price contract is for the delivery of 200-unit vials of the medication Botox. The contract has a completion date of September 27, 2024 and was awarded on September 6, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 200-unit vials of Botox, a specialty medication. The fixed-price contract has a ceiling value of $5,821.30 and a performance period ending on September 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) the DLA has with Amerisourcebergen, valued at up to $999,999,999 through...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCUXE
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 200-unit vials of Botox. The contract has a firm fixed price of $11,642.60 and a period of performance through October 11, 2024. This order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/20/24, 9:38 AM